Devices Orthopaedic Neurosurgery Personnel

 News Release - May 12, 2010

Titan Spine Appoints Vice President of Operations

Company Experiencing Significant Growth

MEQUON, Wis.--(HSMN NewsFeed)--Titan Spine announced the appointment of Mark Berg as Vice President of Operations today. Mr. Berg brings over twenty years of operational, manufacturing and engineering leadership experience to Titan from numerous well-respected orthopaedic, spine, dental and biologic companies.

Previously, Mr. Berg served as Vice President of Manufacturing for Biomet 3i in Palm Beach Gardens, FL. Prior to joining Biomet, he was the Senior Director for Specialty Prototype Services as well as Director of Manufacturing and Engineering for Medtronic / Sofamor Danek. Mr. Berg spent an additional twelve years with DePuy in a number of managerial capacities, as well as Process Engineering and New Product Development roles.

Mr. Berg will be responsible for oversight and management of day-to-day operations. The company believes that his experience will accelerate the expansion of Titan’s bio-inspired product portfolio and custom instrumentation needs.

Kevin Gemas, President of Titan Spine, is confident with what Berg brings to the table, “Mark is a great addition to Titan Spine’s executive management team and will no doubt be a significant contributor towards reaching our goals. He will be a tremendous asset as we strive to meet the increasing market demands of our products. Ultimately, I believe Mark’s knowledge of the industry and hands-on approach will help propel us to the next level.”

About the Company – Titan Spine is a privately owned company based in Mequon, WI focusing on the design and manufacturing of bioactive spinal implants. Founded in 2005, the company is committed to providing surgeons with products that optimize treatment for patients with spondylolysthesis, degenerative disk disease, and other pathologies associated with lower back and neck pain.

Source: Titan Spine

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.